SEC Form 4 · accession 0001127602-17-034175
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
C Richard Reese
Director
Period of report
Dec 6, 2017
Accepted (ET)
Dec 8, 2017 · 10:06 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2017 | M | 7,740 | $40.27 | A | 51,444 | D | |
| Common Stock | Dec 6, 2017 | M | 4,540 | $33.93 | A | 55,984 | D | |
| Common Stock | Dec 6, 2017 | M | 4,030 | $43.39 | A | 60,014 | D | |
| Common Stock | Dec 6, 2017 | M | 3,530 | $52.29 | A | 63,544 | D | |
| Common Stock | Dec 6, 2017 | M | 3,140 | $70.29 | A | 66,684 | D | |
| Common Stock | Dec 6, 2017 | S | 10,227 | $102.40 | D | 56,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $40.27 | Dec 6, 2017 | M | 7,740 | D | May 11, 2012 | May 11, 2018 | Common Stock | 7,740 | 0 | D |
| Stock Options (Right to Buy) | $33.93 | Dec 6, 2017 | M | 4,540 | D | May 9, 2013 | May 9, 2019 | Common Stock | 4,540 | 0 | D |
| Stock Options (Right to Buy) | $43.39 | Dec 6, 2017 | M | 4,030 | D | May 8, 2014 | May 8, 2020 | Common Stock | 4,030 | 0 | D |
| Stock Options (Right to Buy) | $52.29 | Dec 6, 2017 | M | 3,530 | D | May 7, 2015 | May 7, 2021 | Common Stock | 3,530 | 0 | D |
| Stock Options (Right to Buy) | $70.29 | Dec 6, 2017 | M | 3,140 | D | May 6, 2016 | May 6, 2020 | Common Stock | 3,140 | 0 | D |